Top Markets
#1 Cortex Cortex +32.42%
#2 龙虾 (Lobster) 龙虾 (Lobster) +30.38%
#3 Akedo Akedo +25.48%
#4 DexNet DexNet +23.19%
#5 Pons Pons +21.68%
#6 wojak wojak +16.75%
#7 APEX APEX +13.93%
#8 OpenEden OpenEden +13.55%
#9 Official Trump Official Trump +11.37%
#10 EXOD EXOD +9.04%
Coin of the day
Cortex Cortex
Ρυθμίσεις
Γλώσσα
Ελληνικά
Νόμισμα
USD
Θέμα
HBM Holdings Limited HBM Holdings Limited

HBM Holdings Limited

2142
Κατάταξη σε μετοχές #7239
HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused... HBM Holdings Limited is a clinical-stage biopharmaceutical enterprise focused on identifying and developing unique antibody-based treatments for a variety of immunological conditions and cancers. The company's pipeline includes several promising assets. In immunology, Batoclimab (HBM9161) is a human monoclonal antibody specifically designed to bind and inhibit the neonatal fragment crystallizable receptor, while Tanfanercept (HBM9036) is under development to address moderate to severe dry eye disease. For oncology, HBM Holdings is advancing various therapies, such as HBM7008, a bispecific antibody targeting tumor-associated antigens, and HBM4003, a human anti-CTLA-4 antibody. Additional cancer candidates in their portfolio include HBM9302 for breast and gastric cancers, HBM7020 for multiple myeloma, and a suite of treatments—HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022—geared towards solid tumors. Furthermore, HBM9022 is being developed to treat SARS-COV-2. Operating globally, HBM Holdings has a presence in Mainland China, the United States, Europe, and other international markets. The company also fosters strategic partnerships for antibody-drug conjugate (ADC) projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was founded in 2016 and is based in Shanghai, People's Republic of China.
Τιμή μετοχής
$1.99
Κεφαλαιοποίηση
$1.67B
Αλλαγή (1 ημέρα)
-4.66%
Αλλαγή (1 έτος)
22.01%
Χώρα
CN
Εμπόριο HBM Holdings Limited (2142)

Κατηγορία

Healthcare
Ιστορικό τιμής μετοχής για την HBM Holdings Limited (2142)
Υψηλότερη τιμή κλεισίματος: $1.98 στις 2026-08-01

Χαμηλότερη τιμή κλεισίματος: $1.35 στις 2020-12-01
Ιστορικό τιμής μετοχής της HBM Holdings Limited από 2020 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2026 (TTM) -0.88%
2025 894.28%
2024 -16.69%
2023 -21.19%
2022 -75.51%
2021 -21.32%
2020 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.36 39.87%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 50.29%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $121.53 -12.48%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.81 475.44%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.74%
CH